Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 3 R · 1 D cosponsors

SB 946 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

Last action — Referred to HEALTH AND HUMAN SERVICES, July 23, 2025

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced July 23, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 38% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 4 sponsors

    1 primary, 3 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (3 R · 1 D) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Bill to Classify Tianeptine as a Schedule II Controlled Substance

Bill Text

We don't have the full text on file for this bill yet.

Read SB 946 on the official Pennsylvania source →

Action History

  1. Referred to HEALTH AND HUMAN SERVICES, July 23, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 3 co-sponsors · 249 not signed on

Sponsors (1)

Co-sponsors (3)

Not signed on (249)

249 members have not signed on to this bill.

Show all 249 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 946 do?
Bill to Classify Tianeptine as a Schedule II Controlled Substance
Who sponsors SB 946?
SB 946 is sponsored by Nick Miller (Democratic), Doug Mastriano (Republican), Daniel Laughlin (Republican), and Michele Brooks (Republican).
What is the current status of SB 946?
This bill is in committee in the Senate. Introduced July 23, 2025. It must pass committee before a floor vote.
Where can I track SB 946?
Track SB 946 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 946

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 946

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →